Infinity Pharmaceuticals Inc.

NASDAQ:INFI   9:33:14 AM EDT
1.84
+0.03 (+1.66%)
Other Pre-Announcement

Infinity Pharma Reports Q3 Loss Per Share Of $0.16

Published: 11/09/2020 22:26 GMT
Infinity Pharmaceuticals Inc (INFI) - Q3 Loss per Share $0.16.
Q3 Earnings per Share Estimate $-0.16 -- Refinitiv Ibes Data (analyst estimates).
Cash Runway Through 2021.
Expects Net Loss for 2020 to Range From $35 Million to $45 Million.
Infinity Pharmaceuticals - Expects to End 2020 With Year-end Cash, Cash Equivalents, Available-for-sale Securities Balance $25 Million - $35 Million.